LRRC32 and lung carcinoma: Our data suggested that GARP expression was increased in the Tregs from tumor tissues of patients with lung cancer and the proportion of GARP-expressing Tregs was obviously higher in lung cancer patients without lymph node metastasis or distant metastasis and in patients with early clinical stage.